Pregnancy in SpA Patients: Dr Rachel Tate ( @uptoTate) #ACR20 https://t.co/GPrwd9HU5W https://t.co/TbwN4dZNul

• https://bit.ly/3lug6zz

#BestACR20Tweets RT @MeralElRamahiMD : Wonder if you can predict which pts you can taper off bDMARDs? Abst#1538 from Denmark showed that a neg IgM-RF (OR 0.26); low Doppler serum score for 24 jts predicted discontinuation of bDMARDs at 2yr f/u in RA pts w/ DAS28-CRP<2.6. https://t.co/6hv5M1CQwT

#BestACR20Tweets RT @bella_mehta :Anakinra in #Stills disease - Dbl blind, placebo controlled RCT in Stills disease total 12pts, 6 placebo, 6 Rx grp. All pts reached ACR70 at wk 2 without fever and sustained it at 12 weeks. 5/6 reached ACR90 ABS#1633 https://t.co/CCL6GONnvX https://t.co/KaoXBj3Azp

• https://bit.ly/3qheFbk

Coal Miners and RA: Dr Janet Pope ( @Janetbirdope) reviews abstract #1462 presented at #ACR20. https://t.co/frZ3uYNsuA https://t.co/nFHmzYA8KS

• https://bit.ly/3mzbnOl

Revist #ACR20. The RheumNow podcast on Day 2, Part I is available for download. https://t.co/VAPnzYtCIK https://t.co/Pm9g8S1jmn

• https://bit.ly/3eFCC6I

#BestACR20Tweets RT @RichardPAConway : Dr Benard reports an SLR and meta-analysis of 27 studies comparing 2 rituximab regimes in AAV. 375mg x4 and 1000mg x2 equivalent. Remission in 91% vs 85%. Similar adverse event rates @rheumnow #ACR20 Abstr#2048 https://t.co/6fQNzqsvby

• https://bit.ly/3mwa5UC

#BestACR20Tweets RT @doctorRBC : Rheumatology reimbursement by CMS: ""If all goes well, in a few months, you will see a 16% increase in rheumatology."" - From ACR Advocacy Updates @RheumNow #ACR20 Abs#5M017

Is COVID19 infection bad for rheumatic disease patients? Dr. Jeff Curtis ( @RADoctor) reviews abstract L01 presented at #ACR20. https://t.co/hm7geJKzNt https://t.co/gAY6k7ywLw

• https://bit.ly/36vJYYg

#BestACR20Tweets RT @ejdein1 : Draft #ACR20 Rx Recommendations for RA: MTX monotherapy conditionally rec over csDMARD dual or triple Rx, MTX+TNFi @RheumNow https://t.co/HUucJOgQgN https://t.co/xJB2zU1y2U

• https://bit.ly/37EAbP5

Dr. Jack Cush interviews Dr. Petri about the comparative value of lupus anticoagulant vs. other antiphospholipid antibody tests and their role in CVA or MI. #ACR20 https://t.co/IyeRDzw4BC https://t.co/k5LpJ8kkaz

• https://bit.ly/3lycD3g

#BestACR20Tweets RT @RHEUMarampa : Novel predictors of early mortality in a cohort of GCA pts from Portugal: 🚩Older age at dx 🚩Tongue claudication 🚩Prior tx w/ anticoag BP treatment at dx - predictor of early survival. @RheumNow #ACR20 abs1935 https://t.co/vCi2gMCmKE https://t.co/HuTv1p8Yua

• https://bit.ly/36rcUAA

The Lungs: The Alpha and Omega of RA with Dr. Jonathan Kay #ACR20 https://t.co/zhCRaeKOfu https://t.co/zVwgzu9ULs

• https://bit.ly/3olQmYf

Blood Brain Barrier Leakage in SLE: Dr. Janet Pope ( @Janetbirdope) reviews abstract #1508 from #ACR20 meeting. https://t.co/JSHyuGtv3O https://t.co/pGaskVnCfi

• https://bit.ly/3oi1Fka

Revisit Day 1 of #ACR20 through the RheumNow podcast. Follow the link below or find us on Apple/Android podcasts. https://t.co/Hj4uIYzFuL https://t.co/WXecOcVDQR

• https://bit.ly/3ogdYgL

#BestACR20Tweets RT @ejdein1 : Draft #ACR20 Rx Recs for RA: Use MTX, starting oral but remember MTX tricks to maximize success. Folic acid, split dosing, SubQ all keys per Dr. O'Dell to maximize @RheumNow. https://t.co/OEAGi0bSZH https://t.co/aHsHF1Vm4l

• https://bit.ly/3fVf922